世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測

• 英文タイトル：Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7488
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・リソソーム酸リパーゼ欠乏症（LAAL）の治療の世界市場規模
・主要企業別市場シェア
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の世界市場規模：種類別（酵素補充療法、腎臓移植、幹細胞移植）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の世界市場規模：用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））
・リソソーム酸リパーゼ欠乏症（LAAL）の治療のアメリカ市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療のヨーロッパ市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の中国市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の日本市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の東南アジア市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療のインド市場規模（種類別、用途別）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の世界市場予測（2019年-2025年）
・リソソーム酸リパーゼ欠乏症（LAAL）の治療の地域別市場予測（2019年-2025年）
...

Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31.In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and North America are expected to boost lysosomal acid lipase deficiency treatment market.
In 2018, the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lysosomal Acid Lipase Deficiency (LAAL) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Acid Lipase Deficiency (LAAL) Treatment development in United States, Europe and China.

The key players covered in this study
Merck
Pfizer
AstraZeneca
Alexion Pharmaceutical
Lonza Group
Thermo Fisher Scientific
Teva Pharmaceutical
…

Market segment by Type, the product can be split into
Enzyme Replacement Therapy
Kidney Transplantation
Stem Cell Transplantation

Market segment by Application, split into
Wolman Disease
Cholesterol Ester Storage Disease (CESD)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lysosomal Acid Lipase Deficiency (LAAL) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Acid Lipase Deficiency (LAAL) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lysosomal Acid Lipase Deficiency (LAAL) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Enzyme Replacement Therapy
1.4.3 Kidney Transplantation
1.4.4 Stem Cell Transplantation
1.5 Market by Application
1.5.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2025)
1.5.2 Wolman Disease
1.5.3 Cholesterol Ester Storage Disease (CESD)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size
2.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Growth Trends by Regions
2.2.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions (2014-2025)
2.2.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Manufacturers
3.1.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players Head office and Area Served
3.3 Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product/Solution/Service
3.4 Date of Enter into Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019)
4.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
5.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in United States
5.3 United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
5.4 United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

6 Europe
6.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
6.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in Europe
6.3 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
6.4 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

7 China
7.1 China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
7.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in China
7.3 China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
7.4 China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

8 Japan
8.1 Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
8.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in Japan
8.3 Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
8.4 Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
9.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
9.4 Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

10 India
10.1 India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
10.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in India
10.3 India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
10.4 India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (2014-2019)
11.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Players in Central & South America
11.3 Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type
11.4 Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.1.4 Merck Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.2.4 Pfizer Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.3.4 AstraZeneca Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Alexion Pharmaceutical
12.4.1 Alexion Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.4.4 Alexion Pharmaceutical Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.4.5 Alexion Pharmaceutical Recent Development
12.5 Lonza Group
12.5.1 Lonza Group Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.5.4 Lonza Group Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.5.5 Lonza Group Recent Development
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.6.4 Thermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.6.5 Thermo Fisher Scientific Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Introduction
12.7.4 Teva Pharmaceutical Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Key Market Segments
Table Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Covered
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Market Share by Type 2014-2025
Figure Enzyme Replacement Therapy Figures
Table Key Players of Enzyme Replacement Therapy
Figure Kidney Transplantation Figures
Table Key Players of Kidney Transplantation
Figure Stem Cell Transplantation Figures
Table Key Players of Stem Cell Transplantation
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Wolman Disease Case Studies
Figure Cholesterol Ester Storage Disease (CESD) Case Studies
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Report Years Considered
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2025 (Million US$)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions 2014-2019
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions 2014-2019
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Manufacturers in 2018
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Product/Solution/Service
Table Date of Enter into Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Share by Type (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Market Share by Type (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Share by Application (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Application in 2018
Figure United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Figure Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share (2018-2019)
Table Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Type (2014-2019)
Table Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Alexion Pharmaceutical Company Details
Table Alexion Pharmaceutical Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure Alexion Pharmaceutical Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Alexion Pharmaceutical Recent Development
Table Lonza Group Company Details
Table Lonza Group Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure Lonza Group Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Lonza Group Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Share by Regions (2019-2025)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Share by Regions in 2025
Figure United States Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Product (2019-2025)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Product in 2025
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application (2019-2025)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のチロシンヒドロキシラーゼ欠乏症の治療市場：市場規模・現状・予測

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2019-2025
QYR9N8152 2019年6月14日 92Pages
当資料は、チロシンヒドロキシラーゼ欠乏症の治療のグローバル市場について調査・分析したレポートで、種類別（薬、言語療法、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測

Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
QYR9N8091 2019年6月14日 98Pages
当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...

世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7362 2019年6月14日 98Pages
当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界の性感染症（STD）の治療市場：市場規模・現状・予測

Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025
QYR9N8027 2019年6月14日 97Pages
当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7871 2019年6月14日 92Pages
当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測

Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7216 2019年6月14日 92Pages
当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測

Global Lysosomal Storage Diseases Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7490 2019年6月14日 97Pages
当資料は、リソソーム蓄積症治療薬のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、幹細胞療法、基板削減療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測

Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2019-2025
QYR9N7489 2019年6月14日 94Pages
当資料は、リソソーム蓄積症（LSD）のグローバル市場について調査・分析したレポートで、種類別（脂質代謝異常、糖タンパク質代謝異常）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測

Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
QYR9N8151 2019年6月14日 99Pages
当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の補体欠乏症テスト市場：市場規模・現状・予測

Global Complement Deficiency Tests Market Size, Status and Forecast 2019-2025
QYR9N7008 2019年6月14日 92Pages
当資料は、補体欠乏症テストのグローバル市場について調査・分析したレポートで、種類別（血清学的および免疫学的アッセイ、分子診断テスト、免疫組織化学技術、その他）、用途別（病院、診断研究所、研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測 Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Europe is estimated to be the domin…
世界のチロシンヒドロキシラーゼ欠乏症の治療市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測 Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Dis…
世界の臓器移植市場：市場規模・現状・予測 Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or…
世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…